SPIKE PLUS NUCLEOCAPSID VACCINE PROTECTS AGAINST SARS-CoV-2 DELTA INFECTION in NHPs

Authors

• Nanda Kishore Routhu, Emory Vaccine Center, Atlanta, GA
• Sailaja Gangadhara, Emory Vaccine Center, Atlanta, GA
• Lilin Lai, Emory Vaccine Center, Atlanta, GA
• Ayalnesh Shiferaw, Emory Vaccine Center, Atlanta, GA
• Stephanie Fischinger, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
• Bartsch Yannic, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
• Sheikh A. Rahman, Emory Vaccine Center, Atlanta, GA
• Sherrie M. Jean, Yerkes National Primate Research Center, Atlanta, GA
• Chelsea Wallace, Yerkes National Primate Research Center, Atlanta, GA
• Rachelle L. Stammen, Yerkes National Primate Research Center, Atlanta, GA
• Pamela A. Kozlowski, LSU Health Sciences Center - New OrleansFollow
• Galit Alter, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
• Mehul Suthar, Emory University, Atlanta, GA
• Rama R. Amara, Emory Vaccine Center, Atlanta, GA

Document Type

Conference Proceeding

Publication Date

3-1-2022

Publication Title

Topics in Antiviral Medicine

Abstract

Conference on Retroviruses and Opportunistic Infections, CROI 2022, February 12-24, 2022, Online

First Page

94

Volume

30

Issue

1 SUPPL

Comments

Abstract 251

Recommended Citation

Routhu, Nanda Kishore; Gangadhara, Sailaja; Lai, Lilin; Shiferaw, Ayalnesh; Fischinger, Stephanie; Yannic, Bartsch; Rahman, Sheikh A.; Jean, Sherrie M.; Wallace, Chelsea; Stammen, Rachelle L.; Kozlowski, Pamela A.; Alter, Galit; Suthar, Mehul; and Amara, Rama R., "SPIKE PLUS NUCLEOCAPSID VACCINE PROTECTS AGAINST SARS-CoV-2 DELTA INFECTION in NHPs" (2022). School of Graduate Studies Faculty Publications. 642.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/642